OraSure Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Date: September 22, 2003
Reporting Period: Current Report (Event Date: September 22, 2003)
Business Context: The Company operates in the diagnostic testing sector, specifically focusing on oral fluid drug detection systems.
Key Financial Metrics
This filing is a Current Report on Form 8-K regarding a regulatory event. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material event reported is the submission of a regulatory application. There are no reported changes to financial performance or operational status other than this regulatory filing.
Guidance, Outlook, and Management Commentary
- Regulatory Action: The Company announced the filing of an application with the U.S. Food and Drug Administration (FDA) for 510(k) clearance.
- Product: The application concerns the UP link® rapid point-of-care oral fluid drug detection system.
- Outlook: The filing indicates a strategic step toward market approval for the new system, though no specific timeline for clearance or revenue impact is provided in this document.
Investor Verification Checklist
- Verify the status of the 510(k) clearance application for the UP link® system with the FDA.
- Review the attached press release (Exhibit 99) for detailed product specifications and market strategy.
- Monitor future filings for the outcome of the FDA review and any associated commercialization timelines.
- Check subsequent quarterly reports (10-Q) or annual reports (10-K) for financial impact once the product is cleared and commercialized.